<DOC>
	<DOCNO>NCT02425462</DOCNO>
	<brief_summary>This study prospective observational cohort study . The study conduct routine clinical practice setting . It plan enroll 870 patient endometriosis decision make physician treat dienogest accord local health authority approve label . It aim observational cohort study characterize effectiveness dienogest improve quality life long-term safety routine clinical practice set . Endometriosis chronic progressive disease unmet need long-term treatment . Visanne® proven efficacy safety , good option long-term treatment , however , experience Visanne® beyond 15 month limit . And long-term 24 month data effectiveness safety Visanne would support long-term treatment strategy Endometriosis management clinical practice .</brief_summary>
	<brief_title>To Evaluate Effectiveness Visanne Improving Quality Life Asian Women With Endometriosis</brief_title>
	<detailed_description />
	<mesh_term>Endometriosis</mesh_term>
	<mesh_term>Dienogest</mesh_term>
	<criteria>Asian Female patient least 18 year age Clinical surgical diagnosis endometriosis ( depend local approve indication ) : Clinical diagnosis suggestive symptom positive find imaging study ( Chocolate cyst ) Patients Endometriosis associate pelvic pain Decision take physician newly prescribe Visanne® Availability sign informed consent Patients participate investigational program intervention outside routine clinical practice Patients contraindication list local summary product characteristic ( SPC ) apply .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>